Sign in / Join Now
ETFs & Funds
"Study Digs Into Secrets of Keeping HIV in Check." This will be big. Maybe Merck (
) will make a vaccine.
Add a reply...
Latest StockTalks »
people get MRK breaking news and analysis by email alert.
Get email alerts on MRK »
Merck & Co Inc.
Get latest price
From other sites
KEYTRUDA® (pembrolizumab) Demonstrated Improved Health-Related Quality Of Life Compared To Chemotherapy In First-Line Treatment Of Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)
at TheStreet (Wed, 2:45AM)
Merck's Consumer Health Business Drives Consumer-Centric, Purposeful Innovation
at TheStreet (Tue, 9:00AM)
Updated KEYTRUDA® (pembrolizumab) Data In Small Cell Lung Cancer And Mesothelioma Presented At 17th World Conference On Lung Cancer
at TheStreet (Tue, 8:20AM)
KEYTRUDA® (pembrolizumab) Treatment Results In Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma (cHL) Presented At 58th Annual Meeting Of The American Society Of Hematology
at TheStreet (Mon, 7:30PM)
Updated KEYTRUDA® (pembrolizumab) Findings In Patients With Relapsed Or Refractory Primary Mediastinal Large B-Cell Lymphoma Presented At 58th Annual Meeting Of The American Society Of Hematology
at TheStreet (Mon, 10:42AM)